Abstract
Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
Nihal H Fathi, Frank Mitros, John Hoffman, Nicholas Straniero, Douglas Labreque, Rachelle Koehnke and Daniel E Furst
The Journal of Rheumatology October 2002, 29 (10) 2092-2098;
Nihal H Fathi
Frank Mitros
John Hoffman
Nicholas Straniero
Douglas Labreque
Rachelle Koehnke
In this issue
Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
Nihal H Fathi, Frank Mitros, John Hoffman, Nicholas Straniero, Douglas Labreque, Rachelle Koehnke, Daniel E Furst
The Journal of Rheumatology Oct 2002, 29 (10) 2092-2098;
Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
Nihal H Fathi, Frank Mitros, John Hoffman, Nicholas Straniero, Douglas Labreque, Rachelle Koehnke, Daniel E Furst
The Journal of Rheumatology Oct 2002, 29 (10) 2092-2098;